ARHGEF2 and cystic kidney disease: Renal cyst formation was alleviated (Figure 2G–I), and renal fibrosis and inflammation improved (Figure 3A,B) in GEF-H1 knockdown NPHP1KO mice compared with control NPHP1KO mice.